We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
19 hedge funds and large institutions have $69.7M invested in ADMA Biologics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
27% more capital invested
Capital invested by funds: $55.1M → $69.7M (+$14.7M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
30% less funds holding
Funds holding: 27 → 19 (-8)
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Holders
19
Holders Change
-8
Holders Change %
-29.63%
% of All Funds
0.51%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
2
Increased
7
Reduced
4
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$4.66M |
| 2 |
IHM
Iguana Healthcare Management
New York
|
+$1.11M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$147K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$98.9K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$53.1K |
Top Sellers
| 1 |
JGC
J. Goldman & Co
New York
|
-$855K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$595K |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$446K |
| 4 |
TI
Telemetry Investments
New York
|
-$254K |
| 5 |
PVI
Pura Vida Investments
New York
|
-$217K |
